Is BridgeBio Pharma, Inc. stock a buy or sell right now?

BridgeBio Pharma, Inc. currently trades in a Neutral range, with momentum and trend indicators showing no clear direction.

What is BridgeBio Pharma, Inc.’s RSI?

RSI is 48.91, showing balanced momentum within the normal range.

What does MACD indicate for BBIO?

MACD at -1.15 shows bearish pressure, with downside momentum building.

What are BridgeBio Pharma, Inc.’s key support and resistance levels?

Support sits around $62.01, while resistance is near $75.75.

BridgeBio Pharma, Inc.

BBIO•NASDAQ

Healthcare

Biotechnology

$69.41

$1.43(2.10%)

U.S. Market opens in 14h 30m

BridgeBio Pharma, Inc. (BBIO) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for BridgeBio Pharma, Inc. (NASDAQ:BBIO).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

BBIO Technical Analysis Summary

BridgeBio Pharma, Inc. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral

Momentum:Neutral to Bearish (RSI: 48.91)

Trend Strength:Weak (ADX: 18.38)

Volatility:High (ATR: 3.77)

Support/Resistance:$62.01 – $75.75 (Bollinger Bands)

Technical conditions suggest BridgeBio Pharma, Inc. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 48.91

Bearish

Below midpoint indicates downward pressure.

Stochastic %K: 51.93

Neutral

Mid-range signal with no clear trend.

Williams %R: -49.47

Neutral

Balanced market without strong signals.

Rate of Change (ROC): 2.21

Bullish

Steady upward momentum.

Takeaway:BridgeBio Pharma, Inc. shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: -1.15

Bearish

Bearish, trend momentum is strengthening to the downside.

ADX: 18.38

Weak

Weak trend, market trading sideways.

ATR (14): 3.77

Medium

Medium volatility, healthy price movement.

CCI (14): 59.96

Bullish

Bullish, momentum building upward.

Takeaway:BridgeBio Pharma, Inc. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators

Bollinger Bands

Upper Band

$75.75

Middle Band (SMA 20)

$68.88

Lower Band

$62.01

Current Position

Within Bands

Takeaway:BridgeBio Pharma, Inc. trades around the middle band, reflecting balanced price action.

Keltner Channels

Upper Channel

$76.86

Middle Line (EMA 20)

$69.32

Lower Channel

$61.77

Squeeze Status

Squeeze On

Takeaway:BridgeBio Pharma, Inc. trades around the middle line, reflecting balanced price action.

Volume & Money Flow Analysis

On-Balance Volume-8.11M

Money Flow Index43.37Neutral, balanced money flows with no clear signal.

Relative Vigor Index43.95Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:BBIO shows balanced money flow with a slight bearish tilt.

Technical Trading Signals Summary

Based on the current technical analysis of BridgeBio Pharma, Inc., here are the key trading signals and recommendations:

Bullish Signals

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for BridgeBio Pharma, Inc. are mixed, suggesting a Hold or wait-and-see approach.